Pactamycin [paktamycin]
topical
Persistent link
https://www.medvik.cz/link/D010142
Definition
Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis.
- DUI
- D010142 MeSH Browser
- CUI
- M0015738
- CAS
- Benzoic acid, 2-hydroxy-6-methyl-, (5-((3-acetylphenyl)amino)-4-amino-3-(((dimethylamino)carbonyl)amino)-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl)methyl ester, (1S-(1alpha,2beta,3alpha,3(R*),4alpha,5beta))-
- Previous indexing
- Antibiotics, Antineoplastic (1972-1974)
- History note
- 91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
- Public note
- 91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.241.223.100.300.350
Hydroxybenzoate Ethers
D02.241.223.100.300.400
Hydroxymercuribenzoates
D02.241.223.100.300.450
Pactamycin
D02.241.511.390.350
Hydroxybenzoate Ethers
D02.241.511.390.400
Hydroxymercuribenzoates
D02.241.511.390.450
Pactamycin
D02.455.426.559.389.127.281.350
Hydroxybenzoate Ethers
D02.455.426.559.389.127.281.400
Hydroxymercuribenzoates
D02.455.426.559.389.127.281.450
Pactamycin
D02.455.426.559.389.657.410.400
Hydroxymercuribenzoates
D02.455.426.559.389.657.410.450
Pactamycin